Showing results (331-340 of 574) with videos related to
Sort By:
Pageof 58
Cancer|July 11, 1998
How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients?I I Raad, D Abi-Said, K V Rolston, et al.Antimicrobial Agents and Chemotherapy|September 1, 1984
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patientsL Jadeja, R Bolivar, V Fainstein, et al.Blood|August 1, 1982
Evaluation of AMSA in previously treated patients with acute leukemia: results of therapy in 109 adultsS S Legha, M J Keating, K B McCredie, et al.Journal of Medicine|January 1, 1980
Comparative distribution of Baker's antifolate (NSC 139105) in rat tissues after subcutaneous and intravenous injectionsB C Yang, D H Ho, N S Brown, et al.Journal of Surgical Oncology|January 1, 1981
Combination therapy for advanced malignant melanoma with BCNU, pseudomonas vaccine, and heparinR D Snyder, G N Hortobagyi, G P Bodey, et al.Chemotherapy|September 1, 1996
Survey of antibiotic susceptibility among gram-negative bacilli at a cancer centerK V Rolston, L Elting, S Waguespack, et al.Cancer Treatment Reports|November 1, 1979
Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancerS S Legha, G R Blumenschein, A U Buzdar, et al.Genetics|December 5, 2000
spe-29 encodes a small predicted membrane protein required for the initiation of sperm activation in Caenorhabditis elegansJ Nance, E B Davis, S WardCancer Treatment Reports|October 1, 1978
Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracilA Y Bedikian, R Staab, R Livingston, et al.Cancer Treatment Reports|September 1, 1984
Phase I clinical investigation of homoharringtonineS S Legha, M Keating, S Picket, et al.Pageof 58